ARS Pharmaceuticals, Inc. (SPRY)

$9.59 +3.68%
EARNINGS ANALYTICS
event_note Approx. Next Earnings: ~2026-08-10 APPROXIMATE
search

Since Mar 29, 2021, ARS Pharmaceuticals, Inc. (SPRY) has reported earnings 20 times. On average the shares move ±5.56% post-earnings, with a positive reaction 30.0% of the time. Its largest post-earnings gain was +22.83% (Mar 20, 2025) and its largest decline was -15.23% (Nov 13, 2024). The next earnings report is predicted for 2026-08-10 (approximate).

Earnings Price Reaction

Scroll to zoom, drag to pan — click earnings dots for details

Beat Miss

Earnings Impact

Total Earnings

20

Avg Abs. Movement

±5.56%

Positive %

30.0%

Negative %

70.0%

Historical Earnings Statistics

Date Timing Open High Close Volume Movement % SEC Filing
May 15, 2026 ☀ PRE $7.65 $7.80 $7.42 176,562 -6.43% open_in_new
Mar 09, 2026 ☀ PRE $9.34 $9.50 $9.05 1,703,600 -0.11% open_in_new
Nov 10, 2025 ☀ PRE $10.00 $10.31 $8.88 4,106,000 +0.34% open_in_new
Aug 13, 2025 ☀ PRE $16.50 $16.65 $15.82 4,312,400 -5.04% open_in_new
May 14, 2025 ☀ PRE $12.26 $13.01 $12.10 3,524,700 -9.36% open_in_new
Mar 20, 2025 ☀ PRE $12.30 $15.09 $14.31 8,868,800 +22.83% open_in_new
Nov 13, 2024 ☀ PRE $16.11 $16.51 $14.08 3,202,100 -15.23% open_in_new
Aug 06, 2024 ☽ POST $9.51 $10.00 $9.78 448,800 -2.2% open_in_new
May 09, 2024 ☽ POST $9.06 $9.19 $8.80 332,200 -0.68% open_in_new
Mar 21, 2024 ☽ POST $8.85 $9.00 $9.00 731,500 -3.89% open_in_new
Nov 09, 2023 ☽ POST $3.60 $3.64 $3.43 386,200 +8.75% open_in_new
Aug 10, 2023 ☽ POST $6.96 $7.10 $6.85 353,200 -0.29% open_in_new
May 15, 2023 ☀ PRE $8.11 $8.39 $7.81 4,074,800 -2.86% open_in_new
Mar 23, 2023 ☽ POST $8.01 $8.14 $7.91 117,700 -4.05% open_in_new
May 12, 2022 ☽ POST $2.85 $3.03 $3.03 563,500 -2.31% open_in_new
Mar 31, 2022 ☽ POST $3.48 $3.52 $3.51 335,800 -8.55% open_in_new
Nov 10, 2021 ☽ POST $8.33 $8.55 $8.23 288,700 +2.31% open_in_new
Aug 12, 2021 ☽ POST $28.17 $28.98 $28.11 137,600 +3.09% open_in_new
May 13, 2021 ☽ POST $26.59 $27.13 $24.71 131,400 +7.32% open_in_new
Mar 29, 2021 ☽ POST $47.00 $47.39 $43.00 91,200 -5.65% open_in_new
event

Earnings Count

20

Total earnings in dataset

trending_up

Avg Abs. Movement

±5.56%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

SEC Filing Types

Recent SEC Filings

10 most recent
Form Date Filed View on EDGAR
3 20260601 open_in_new SEC.gov
10-Q 20260515 open_in_new SEC.gov
8-K 20260515 open_in_new SEC.gov
SCHEDULE 13G/A 20260515 open_in_new SEC.gov
8-K 20260513 open_in_new SEC.gov
ARS 20260429 open_in_new SEC.gov
DEFA14A 20260429 open_in_new SEC.gov
DEF 14A 20260429 open_in_new SEC.gov
ARS 20260429 open_in_new SEC.gov
DEF 14A 20260429 open_in_new SEC.gov

Frequently asked about SPRY earnings

When does ARS Pharmaceuticals, Inc. report earnings next? expand_more

ARS Pharmaceuticals, Inc. (SPRY)'s next earnings date is approximate for 2026-08-10. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does SPRY stock move after earnings? expand_more

Over 20 reports, SPRY has moved an average of ±5.56% the session after earnings, closing higher 30.0% of the time.

What was SPRY's biggest post-earnings move? expand_more

SPRY's largest post-earnings gain on record was +22.83% on Mar 20, 2025, and its largest decline was -15.23% on Nov 13, 2024.

Where can I find ARS Pharmaceuticals, Inc.'s SEC filings? expand_more

All of ARS Pharmaceuticals, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.

Sector peers